Aaron Cowen’s LENZ Therapeutics LENZ Stock Holding History

Aaron Cowen’s Portfolio LENZ Stock Details LENZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-17,857	Closed	-$3.84M	–	131
2021 Q2	$3.84M	Buy	+17,857	New	+$3.11M	0.06%	95

Other funds holding LENZ

Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return

VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Aaron Cowen's LENZ Position: Q3 2021 in Review

Aaron Cowen sold out of LENZ Therapeutics (LENZ) in Q3 2021, closing a stake of 17,857 shares — an estimated $3.84M sold.

Aaron Cowen first reported a position in LENZ in Q2 2021 and held it in 1 quarter. The position peaked at $3.84M in Q2 2021. 60 funds tracked by Wall St. Rank hold LENZ as of Q3 2021.

Aaron Cowen reported no remaining LENZ Therapeutics position as of Q3 2021 after selling out during the quarter.
Aaron Cowen sold 17,857 LENZ Therapeutics shares in Q3 2021, an estimated $3.84M.
Aaron Cowen first reported a position in LENZ Therapeutics in Q2 2021 and held it in 1 quarter.
Aaron Cowen's LENZ Therapeutics position peaked at $3.84M in Q2 2021.
60 funds tracked by Wall St. Rank held LENZ Therapeutics as of Q3 2021.

Based on Suvretta Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.